Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2607-2614
Published online before print May 12, 2003, doi: 10.1161/01.CIR.0000066909.13953.F1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/20/2607    most recent
01.CIR.0000066909.13953.F1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suschek, C. V.
Right arrow Articles by Kolb-Bachofen, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suschek, C. V.
Right arrow Articles by Kolb-Bachofen, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*HYDROGEN PEROXIDE
*NITRIC OXIDE
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2003;107:2607.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Critical Role of L-Arginine in Endothelial Cell Survival During Oxidative Stress

Christoph V. Suschek, PhD; Oliver Schnorr, PhD; Karsten Hemmrich; Olivier Aust, PhD; Lars-Oliver Klotz, PhD; Helmut Sies, MD; Victoria Kolb-Bachofen, PhD

From the Research Group Immunobiology (C.V.S., O.S., K.H., V.K.-B.) and Institute of Biochemistry and Molecular Medicine I and Biologisch-Medizinisches Forschungszentrum (O.A., L.-O.K., H.S.), Heinrich-Heine-University Duesseldorf, Germany.

Correspondence to Dr Christoph V. Suschek, Research Group Immunobiology, Geb.: 23.12.02, Heinrich-Heine-University Duesseldorf, PO Box 10 10 07, D-40001 Duesseldorf, Germany. E-mail suschek{at}uni-duesseldorf.de

Background— Oxidative damage of vascular endothelium represents an important initiation step in the development of atherosclerosis. Recently, we reported about protection of inducible nitric oxide synthase (iNOS)-derived high-output NO in endothelial cells. Because iNOS activity critically depends on the availability of its substrate L-arginine, the present study aims at elucidating iNOS-mediated effects on H2O2-induced apoptosis of cytokine-activated rat aortic endothelial cells (AECs) subject to medium L-arginine concentrations.

Methods and Results— In cytokine-activated AECs, iNOS activity was found to be half-maximal at 60 µmol/L arginine, which represents the medium serum level in rats but also in humans. Maximal activity is seen at and above 200 µmol/L arginine. Activated cells grown in the absence of arginine with minimal iNOS activity are highly sensitive toward H2O2-induced apoptosis, and increases in medium arginine concentrations result in increased cell survival. Moreover, competition experiments show that iNOS activity is completely dependent on cationic amino acid transporter-mediated arginine uptake. We also find that the arginine-dependent protection includes inhibition of endothelial lipid peroxidation and increases in the expression of vasoprotective stress response genes.

Conclusions— Our data demonstrate that arginine concentrations corresponding to physiological serum levels do not allow for optimal endothelial iNOS activity. Thus, decreases in systemic arginine concentrations, or locally within atherosclerotic plaques, will impair the endothelial iNOS-mediated stress response and will significantly increase the risk of endothelial dysfunction.


Key Words: amino acids • arteriosclerosis • endothelium • inflammation • nitric oxide




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Y. Matsumoto, S. Ueda, S.-i. Yamagishi, K. Matsuguma, R. Shibata, K. Fukami, H. Matsuoka, T. Imaizumi, and S. Okuda
Dimethylarginine Dimethylaminohydrolase Prevents Progression of Renal Dysfunction by Inhibiting Loss of Peritubular Capillaries and Tubulointerstitial Fibrosis in a Rat Model of Chronic Kidney Disease
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1525 - 1533.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Topal, A. Brunet, L. Walch, J.-L. Boucher, and M. David-Dufilho
Mitochondrial Arginase II Modulates Nitric-Oxide Synthesis through Nonfreely Exchangeable L-Arginine Pools in Human Endothelial Cells
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1368 - 1374.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W.-Z. Zhang, K. Venardos, J. Chin-Dusting, and D. M. Kaye
Adverse Effects of Cigarette Smoke on NO Bioavailability: Role of Arginine Metabolism and Oxidative Stress
Hypertension, August 1, 2006; 48(2): 278 - 285.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
J. K. Stechmiller, B. Langkamp-Henken, B. Childress, K. A. Herrlinger-Garcia, J. Hudgens, L. Tian, S. S. Percival, and R. Steely
Arginine Supplementation Does Not Enhance Serum Nitric Oxide Levels in Elderly Nursing Home Residents With Pressure Ulcers
Biol Res Nurs, April 1, 2005; 6(4): 289 - 299.
[Abstract] [PDF]


Home page
CirculationHome page
X.-F. Ming, C. Barandier, H. Viswambharan, B. R. Kwak, F. Mach, L. Mazzolai, D. Hayoz, J. Ruffieux, S. Rusconi, J.-P. Montani, et al.
Thrombin Stimulates Human Endothelial Arginase Enzymatic Activity via RhoA/ROCK Pathway: Implications for Atherosclerotic Endothelial Dysfunction
Circulation, December 14, 2004; 110(24): 3708 - 3714.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Ignjatovic, S. Stanisavljevic, V. Brovkovych, R. A. Skidgel, and E. G. Erdos
Kinin B1 Receptors Stimulate Nitric Oxide Production in Endothelial Cells: Signaling Pathways Activated by Angiotensin I-Converting Enzyme Inhibitors and Peptide Ligands
Mol. Pharmacol., November 1, 2004; 66(5): 1310 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
K.-Y. Chyu, P. C Dimayuga, X. Zhao, J. Nilsson, P. K Shah, and B. Cercek
Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells
Vascular Medicine, August 1, 2004; 9(3): 177 - 183.
[Abstract] [PDF]